Hamzic S., Schärer D., Offer S.M., Meulendijks D., Nakas C., Diasio R.B., Fontana S., Wehrli M., Schürch S., Amstutz U., Largiadèr C.R. (2021)
Aims: The aim of this study was to identify risk variants and haplotypes that impair dihydropyrimidine dehydrogenase (DPD) activity and are, therefore, candidate risk variants for severe toxicity to 5-fluorouracil (5-FU) ...